[HTML][HTML] Efficacy and safety of human bone marrow-derived mesenchymal stem cells according to injection route and dose in a chronic kidney disease rat model
HK Chae, N Suh, MJ Jang, YS Kim… - … Journal of Stem …, 2023 - synapse.koreamed.org
Methods and Results A total of ninety 12-week-old rats underwent 5/6 nephrectomy and
randomized among nine groups: sham, renal artery control (RA-C), tail vein control (TV-C) …
randomized among nine groups: sham, renal artery control (RA-C), tail vein control (TV-C) …
[HTML][HTML] Effects of intravenous administration of allogeneic mesenchymal stromal cells, derived from adipose tissue, in five dogs with chronic kidney disease
M Milistetd, CZ Cavalcante, HSS Brunel… - Arquivo Brasileiro de …, 2022 - SciELO Brasil
This study aimed to evaluate the safety of allogeneic adipose-derived mesenchymal stromal
cell (aASC) treatment in dogs with chronic kidney disease (CKD) at the time of infusions and …
cell (aASC) treatment in dogs with chronic kidney disease (CKD) at the time of infusions and …
[PDF][PDF] 介入再生医学中干细胞治疗研究进展
关斯文， 刘旋， 刘刚 - 中国生物医学工程学报, 2022 - cjbme.csbme.org
介入再生医学(IRM) 是一门通过影像引导微创手术与干细胞的局部递送实现受损器官修复和
再生的交叉学科ꎮ 近年来ꎬ 基于干细胞的再生治疗已在多项疾病的临床试验中显示出应用前景 …
再生的交叉学科ꎮ 近年来ꎬ 基于干细胞的再生治疗已在多项疾病的临床试验中显示出应用前景 …
[PDF][PDF] The therapeutic effect of autologous bone marrow mesenchymal stem cells to prevent the progress of chronic allograft nephropathy
F Gholami, A Ghasemi, AR Bahrami… - Journal of Renal Injury …, 2018 - journalrip.com
Progenitor cells or mesenchymal stem cells are new cells, with renovation and regeneration
ability and tissues repair. In recent years, administration of stem cells has been introduced to …
ability and tissues repair. In recent years, administration of stem cells has been introduced to …
[图书][B] Developing PET/MR Imaging Probes for the in Vivo Tracking of Cell Therapies
N McCallum - 2022 - search.proquest.com
Cell therapies hold enormous potential to treat a range of diseases and disorders. However,
clinical translation of these therapies has been limited, largely due to a lack of sufficient …
clinical translation of these therapies has been limited, largely due to a lack of sufficient …
[HTML][HTML] 肾组织干细胞治疗急性肾衰竭的可行性
胡跃世， 李鹏， 曹志华， 刘磊， 王阳 - 中国组织工程研究, 2017 - cjter.com
摘要背景: 研究表明, 肾组织干细胞主要存在于肾乳头部位, 其具有类似于间充质干细胞的特性,
目前尚不能肯定其是否参与了肾小管上皮细胞损伤的修复. 目的: 探讨肾组织干细胞治疗急性肾 …
目前尚不能肯定其是否参与了肾小管上皮细胞损伤的修复. 目的: 探讨肾组织干细胞治疗急性肾 …
[图书][B] Multimodal imaging to evaluate the distribution and fate of a mesenchymal stromal cell therapy
AH Pichardo - 2022 - search.proquest.com
Mesenchymal stromal cell (MSC) treatments have shown beneficial outcomes in preclinical
models of various diseases, but limited therapeutic effects in clinical trials. This disparity in …
models of various diseases, but limited therapeutic effects in clinical trials. This disparity in …
Adipose derived stromal vascular fraction: therapeutic potential of renal artery administration in renal ischaemia reperfusion injury
R Ghita - 2021 - theses.gla.ac.uk
Shortages of kidneys for transplantation is a universal concern. Countries like the United
Kingdom have had success improving the number of kidneys available notably through …
Kingdom have had success improving the number of kidneys available notably through …